<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Soul of Biotech &#187; amgen</title>
	<atom:link href="http://www.thesoulofbiotech.com/category/amgen/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thesoulofbiotech.com</link>
	<description>Laughter is the best medicine -- but let's cure cancer anyway.</description>
	<lastBuildDate>Mon, 30 Jan 2012 23:45:27 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>You&#8217;re moving WHERE?!?</title>
		<link>http://www.thesoulofbiotech.com/2007/09/11/youre-moving-where/</link>
		<comments>http://www.thesoulofbiotech.com/2007/09/11/youre-moving-where/#comments</comments>
		<pubDate>Tue, 11 Sep 2007 22:05:32 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[amgen]]></category>
		<category><![CDATA[sales]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2007/09/11/youre-moving-where/</guid>
		<description><![CDATA[On Friday afternoon, I formally accepted an offer to transfer into the Enbrel Derm sales force, serving in the Portland, Oregon territory. Relocation timing and details are still pending, but I&#8217;ll probably get up there by October or so. I&#8217;m incredibly excited to learn how to sell effectively. Both my district manager and regional director [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2007/09/11/youre-moving-where/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Do you still have a job?</title>
		<link>http://www.thesoulofbiotech.com/2007/08/26/do-you-still-have-a-job/</link>
		<comments>http://www.thesoulofbiotech.com/2007/08/26/do-you-still-have-a-job/#comments</comments>
		<pubDate>Mon, 27 Aug 2007 00:30:56 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[amgen]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2007/08/26/do-you-still-have-a-job/</guid>
		<description><![CDATA[From Episode 1&#215;14 of Sports Night: Isaac: &#8220;Thanks, this won&#8217;t take long. There&#8217;s gonna be a piece in tomorrow&#8217;s Wall Street Journal. Don&#8217;t worry about it. (BEAT) That&#8217;s all.&#8221; Yes, I still have my job. Furthermore, there&#8217;s no rationale (barring the sale of Amgen to a competitor) by which I would not continue to have [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2007/08/26/do-you-still-have-a-job/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Meet Danny Halperin</title>
		<link>http://www.thesoulofbiotech.com/2007/07/29/meet-danny-halperin/</link>
		<comments>http://www.thesoulofbiotech.com/2007/07/29/meet-danny-halperin/#comments</comments>
		<pubDate>Mon, 30 Jul 2007 01:39:50 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[academia]]></category>
		<category><![CDATA[amgen]]></category>
		<category><![CDATA[interview]]></category>
		<category><![CDATA[pharmacogenomics]]></category>
		<category><![CDATA[r&d]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2007/07/29/meet-danny-halperin/</guid>
		<description><![CDATA[Danny Halperin is a second-year graduate student in Molecular &#038; Cellular Pathology at the University of California at Los Angeles, working in the laboratory of Dr. Peter Tontonoz. Before attending UCLA, Danny spent four years at Amgen in Clinical Immunology supporting pre-clinical and clinical development of biologics. Danny and I sat down over Thai food [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2007/07/29/meet-danny-halperin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(What Danny said)</title>
		<link>http://www.thesoulofbiotech.com/2007/07/22/what-danny-said/</link>
		<comments>http://www.thesoulofbiotech.com/2007/07/22/what-danny-said/#comments</comments>
		<pubDate>Sun, 22 Jul 2007 23:30:11 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[amgen]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2007/07/22/what-danny-said/</guid>
		<description><![CDATA[Normally, I start each post with a single question that I ask myself. This time, I&#8217;m starting with a whole list of great questions that Danny Halperin from UCLA asked in response to my first post. Thanks, Danny! So, I’m curious what kinds of responsibilities do you have in your job? Your background seems to [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2007/07/22/what-danny-said/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is Amgen&#8217;s anemia franchise in trouble?</title>
		<link>http://www.thesoulofbiotech.com/2007/06/02/is-amgens-anemia-franchise-in-trouble/</link>
		<comments>http://www.thesoulofbiotech.com/2007/06/02/is-amgens-anemia-franchise-in-trouble/#comments</comments>
		<pubDate>Sun, 03 Jun 2007 01:54:10 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[amgen]]></category>
		<category><![CDATA[anemia]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2007/06/02/is-amgens-anemia-franchise-in-trouble/</guid>
		<description><![CDATA[If you&#8217;ve been following our news, you may have heard about the FDA&#8217;s warnings on erythropoetic-stimulating agents, or ESAs. ESAs are a class of agents manufactured by Amgen that treat anemia. The first ESA was epoetin alfa, which was marketed in dialysis as Epogen by Amgen, and marketed in non-dialysis indications as Procrit by Johnson [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2007/06/02/is-amgens-anemia-franchise-in-trouble/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 1328339563.146 seconds -->

